TD Asset Management
PRCT icon

TD Asset Management’s Procept Biorobotics PRCT Stock Holding History

TD Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Sell
131,528
-20,206
-13% -$506K ﹤0.01% 903
2026
Q1 		$3.79M Sell
151,734
-11,700
-7% -$330K ﹤0.01% 838
2025
Q4 		$5.14M Buy
163,434
+19,410
+13% +$644K ﹤0.01% 800
2025
Q3 		$5.14M Sell
144,024
-14,246
-9% -$650K ﹤0.01% 786
2025
Q2 		$9.12M Buy
158,270
+40,026
+34% +$2.26M 0.01% 654
2025
Q1 		$6.89M Buy
118,244
+14,044
+13% +$959K 0.01% 727
2024
Q4 		$8.39M Buy
104,200
+16,446
+19% +$1.41M 0.01% 682
2024
Q3 		$6.98M Sell
87,754
-16,394
-16% -$1.16M 0.01% 715
2024
Q2 		$6.36M Sell
104,148
-78,642
-43% -$4.68M 0.01% 708
2024
Q1 		$9.03M Sell
182,790
-31,426
-15% -$1.5M 0.01% 647
2023
Q4 		$8.98M Sell
214,216
-45,600
-18% -$1.55M 0.01% 638
2023
Q3 		$8.52M Buy
259,816
+107,797
+71% +$3.68M 0.01% 615
2023
Q2 		$5.37M Buy
152,019
+14,140
+10% +$468K 0.01% 724
2023
Q1 		$3.92M Buy
137,879
+6,051
+5% +$213K ﹤0.01% 802
2022
Q4 		$5.48M Buy
131,828
+1,600
+1% +$68.7K 0.01% 730
2022
Q3 		$5.27M Sell
130,228
-41,582
-24% -$1.66M 0.01% 738
2022
Q2 		$5.62M Sell
171,810
-12,236
-7% -$445K 0.01% 742
2022
Q1 		$6.44M Buy
184,046
+152,308
+480% +$3.67M 0.01% 765
2021
Q4 		$794K Buy
31,738
+4,275
+16% +$158K ﹤0.01% 1319
2021
Q3 		$1.05M Buy
+27,463
New +$1.05M ﹤0.01% 1241

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

TD Asset Management's PRCT Position: Q2 2026 in Review

TD Asset Management reduced its Procept Biorobotics (PRCT) stake by 13% in Q2 2026, selling an estimated $506K and leaving 131,528 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #903.

TD Asset Management first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $9.12M in Q2 2025. 184 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • TD Asset Management held 131,528 shares of Procept Biorobotics worth $2.97M as of Q2 2026.
  • TD Asset Management sold 20,206 Procept Biorobotics shares in Q2 2026, an estimated $506K.
  • Procept Biorobotics made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #903 holding.
  • TD Asset Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
  • TD Asset Management's Procept Biorobotics position peaked at $9.12M in Q2 2025.
  • 184 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.